๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Diffuse Large B Cell Lymphoma (DLBCL)
Clinical trial register · China

Diffuse Large B Cell Lymphoma (DLBCL) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 4 Lanzhou 1 Dongguan 1 Shantou 1 Shenzhen 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou4 Lanzhou1 Dongguan1 Shantou1 Shenzhen1
All 7 locations
Target enrolment
to

Diffuse Large B Cell Lymphoma (DLBCL) trials in China

4 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
NCT07494565Diffuse Large B-Cell Lymphoma (DLBCL), CD5 Positive
Sun Yat-sen University
Phase 2
60
Guangzhou
2026-03-06
Not yet open
Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study
NCT07398638Diffuse Large B Cell Lymphoma (DLBCL)
Sun Yat-sen University
Phase 1/2
122
Guangzhou
2026-02-28
Recruiting
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
NCT07084662Diffuse Large B-Cell Lymphoma (DLBCL)
Sun Yat-sen University
Phase 2/3
80
Guangzhou
2025-09-11
Recruiting
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients๏ผˆRocket Trial๏ผ‰
NCT06647940Diffuse Large B Cell Lymphoma (DLBCL)
Sun Yat-sen University
Phase 2
39
Guangzhou, Lanzhou, Dongguan, Shantou, Shenzhen, Zhaoqing, Zhuhai
2024-11-01
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/diffuse-large-b-cell-lymphoma-dlbcl

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies listing the condition Diffuse Large B Cell Lymphoma (DLBCL) that also match the filters currently applied.

How many Diffuse Large B Cell Lymphoma (DLBCL) trials are recruiting in China?

3 of the 4 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Diffuse Large B Cell Lymphoma (DLBCL)), 4 studies
PhaseStudiesRecruitingShare
Phase 22250%
Phase 1/21025%
Phase 2/31125%

Most active sponsors

Lead sponsors with the most studies (Diffuse Large B Cell Lymphoma (DLBCL))
Lead sponsorStudiesRecruiting
Sun Yat-sen University43
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.